Stuart McGurnaghan

16PUBLICATIONS

72CO-AUTHORS

Central nervous systemGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Epidemiological modellingMajor global burdens of disease

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 11, 2026

Long-term Effect of C-Peptide Level on Clinical Outcomes in the Scottish Type 1 Bioresource Cohort.

|Aug 11, 2025

Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes.

Xuan Zhou, Andrii Iakovliev, Stuart McGurnaghan

|Nov 18, 2024

Genetics of C-Peptide and Age at Diagnosis in Type 1 Diabetes.

Delnaz Roshandel, Athina Spiliopoulou, Stuart J McGurnaghan

|Jul 22, 2024

Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.

Joseph Mellor, Dmitry Kuznetsov, Simon Heller

|Jun 18, 2024

Impact of COVID-19 and Non-COVID-19 Hospitalized Pneumonia on Longer-Term Cardiovascular Mortality in People With Type 2 Diabetes: A Nationwide Prospective Cohort Study From Scotland.

Stuart J McGurnaghan, Paul M McKeigue, Luke A K Blackbourn

|May 25, 2024

Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.

Joseph Mellor, Dmitry Kuznetsov, Simon Heller

Pageof 3

Frequent Collaborators

14 joint publications

Paul M McKeigue

14 joint publications

Helen M Colhoun

11 joint publications

Luke Blackbourn

Joseph Mellor

Thomas M Caparrotta

Naveed Sattar

Sarah Wild

David McAllister

Rory J McCrimmon

John McKnight

Frequent Collaborators

14 joint publications

Paul M McKeigue

14 joint publications

Helen M Colhoun

11 joint publications

Luke Blackbourn

6 joint publications

Joseph Mellor